Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Wuhan General Group (China), Inc.
No Price
Closing Price OTC 27.04.2026:
0,0003 USD
27.04.2026 20:00
Current Prices from Wuhan General Group (China), Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
WUHN
USD
27.04.2026 20:00
0,0003 USD
0,00 USD
Company Profile for Wuhan General Group (China), Inc. Share
Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.
